<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.nutritionandmetabolism.com/feeds/latestarticles/journal?quantity=&amp;format=rss&amp;version=">
        <title>Nutrition &amp; Metabolism - Latest Articles</title>
        <link>http://www.nutritionandmetabolism.com</link>
        <description>The latest research articles published by Nutrition &amp; Metabolism</description>
        <dc:date>2009-06-16T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/6/1/28" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/6/1/27" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/6/1/26" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/6/1/25" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/6/1/24" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/6/1/23" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/6/1/22" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/6/1/21" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/6/1/20" />
                                <rdf:li rdf:resource="http://www.nutritionandmetabolism.com/content/6/1/19" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/6/1/28">
        <title>Aerobic fitness does not modulate protein metabolism in response to increased exercise: a controlled trial </title>
        <description>Background:
A sudden increase in exercise and energy expenditure is associated with an increase in protein turnover and nitrogen excretion.  This study examined how a sudden increase in exercise-induced energy expenditure affected whole body protein metabolism and nitrogen balance in people of differing levels of aerobic fitness.  We hypothesized that alterations in whole-body protein turnover would be attenuated, and nitrogen balance would be preserved, in individual with higher levels of aerobic fitness.
Methods:
Eleven men, categorized as either having a lower (LOW-FIT; n = 5) or higher (FIT; n =6) aerobic fitness level, completed a 4-d baseline period (BL) of an energy balance diet while maintaining usual physical activity level, followed by a 7-d intervention consisting of 1,000 kcald-1 increased energy expenditure via exercise (50-65% VO2 peak).  All volunteers consumed 0.9 g proteinkg-1d-1 and total energy intake was adjusted to maintain energy balance throughout the 11-d study.  Mean nitrogen balance (NBAL) was determined for BL, days 5-8 (EX1), and days 9-11 (EX2). Whole-body protein turnover was derived from phenylalanine and tyrosine kinetics assessed while fasting at rest on days 4, 7, and 12 using a priming dose of L-[ring-15N]tyrosine and a 4-h primed, continuous infusion of L-[15N]phenylalanine and L-[ring-2H4]tyrosine.
Results:
A significant main effect of time indicated that NBAL increased over the course of the intervention; however, a group-by-time interaction was not observed.  Although FIT demonstrated a lower net protein oxidation and higher net protein balance compared to LOW-FIT, neither the effect of time nor a group-by-time interaction was significant for Phe flux, net protein oxidation, or derived whole-body protein synthesis and net protein balance.
Conclusion:
The absence of significant group-by-time interactions in protein metabolism (i.e., NBAL and whole-body protein turnover) between LOW-FIT and FIT males suggest that aerobic fitness level does not modulate protein &quot;sparing&quot; in response to an unaccustomed increase in energy expenditure.</description>
        <link>http://www.nutritionandmetabolism.com/content/6/1/28</link>
                <dc:creator>Tracey Smith</dc:creator>
                <dc:creator>Matthew Pikosky</dc:creator>
                <dc:creator>Ann Grediagin</dc:creator>
                <dc:creator>Carmen Castenada-Sceppa</dc:creator>
                <dc:creator>Lauri Byerley</dc:creator>
                <dc:creator>Ellen Glickman</dc:creator>
                <dc:creator>Andrew Young</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2009, 6:28</dc:source>
        <dc:date>2009-06-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-6-28</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>28</prism:startingPage>
        <prism:publicationDate>2009-06-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/6/1/27">
        <title>Fatty acid desaturation index correlates with body mass and adiposity indices of obesity in Wistar NIN obese mutant rat strains WNIN/Ob and WNIN/GR-Ob</title>
        <description>Background:
Microsomal stearoyl-CoA desaturase1 (SCD1) is the rate limiting enzyme involved in the biosynthesis of monounsaturated fatty acids (MUFAs); palmitoleic (16:1) and oleic (18:1) acid from their respective substrates palmitic (16:0) and stearic (18:0) acids. The ratio of 18:1 to 18:0 has been implicated in the regulation membrane fluidity and function. SCD1 is abundantly expressed in obese humans as well as rodent models. However, no studies have correlated the fatty acid desaturation index (16:1/16:0 and 18:1/18:0), an indicator of SCD1 activity with the markers of obesity in terms of body mass index (BMI) and adiposity index (AI). Therefore, here, we attempted to relate the fatty acid desaturation index with BMI and AI in Wistar NIN-obese mutant rat strains namely, WNIN/Ob and WNIN/GR-Ob (with impaired glucose tolerance).
Methods:
For this purpose, 200 days old male 6 lean and 6 obese rats of both strains were taken. Fatty acid composition was analyzed in plasma, various tissues such as liver, white adipose tissues (retroperitoneal, epididymal, omental, and subcutaneous) and brown adipose tissue.
Results:
Fatty acid composition data showed significant increase in palmitoleic (16:1) and oleic (18:1) acid levels, which were reflected in increased desaturation index (16:1/16:0 and 18:1/18:0) in plasma and all the tissues of obese rats of both strains, when compared with their respective age and sex-matched lean rats. Further, we found a strong positive correlation between desaturation index, BMI and AI in plasma and most of the tissues analyzed.
Conclusion:
So far, plasma &#916;9 desaturation index has been well correlated with hypertriglyceridemia and we, by employing two models of obesity namely, WNIN/Ob and WNIN/GR-Ob, have shown &#916;9 desaturation index of plasma correlated with physical markers of obesity such as BMI and AI. In conclusion, &#916;9 desaturation index may serve as a potential sensitive biochemical marker to assess the degree of obesity and impact of therapeutic/nutritional interventions to combat obesity, along with other indicators.</description>
        <link>http://www.nutritionandmetabolism.com/content/6/1/27</link>
                <dc:creator>Shanmugam Jeyakumar</dc:creator>
                <dc:creator>Pratti Lopamudra</dc:creator>
                <dc:creator>Suryaprakash Padmini</dc:creator>
                <dc:creator>Nagalla Balakrishna</dc:creator>
                <dc:creator>Nappan Giridharan</dc:creator>
                <dc:creator>Ayyalasomayajula Vajreswari</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2009, 6:27</dc:source>
        <dc:date>2009-06-11T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-6-27</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>27</prism:startingPage>
        <prism:publicationDate>2009-06-11T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/6/1/26">
        <title>Leucine modulation of mitochondrial mass and oxygen consumption in skeletal muscle cells and adipocytes. </title>
        <description>Background:
The effects of dairy on energy metabolism appear to be mediated, in part, by leucine and calcium which regulate both adipocyte and skeletal muscle energy metabolism. We recently demonstrated that leucine and calcitriol regulate fatty acid oxidation in skeletal muscle cells in vitro, with leucine promoting and calcitriol suppressing fatty acid oxidation. Moreover, leucine coordinately regulated adipocyte lipid metabolism to promote flux of lipid to skeletal muscle and regulate metabolic flexibility. We have now investigated the role of mitochondrial biogenesis in mediating these effects.
Methods:
We tested the effect of leucine, calcitriol and calcium in regulation of mitochondrial mass using a fluorescence method and tested mitochondrial biogenesis regulatory genes as well mitochondrial component genes using real-time PCR. We also evaluated the effect of leucine on oxygen consumption with a modified perfusion system.
Results:
Leucine (0.5 mM) increased mitochondrial mass by 30% and 53% in C2C12 myocytes and 3T3-L1 adipocytes, respectively, while calcitriol (10 nM) decreased mitochondrial abundance by 37% and 27% (p &lt; 0.02). Leucine also stimulated mitochondrial biogenesis genes SIRT-1, PGC-1&#945; and NRF-1 as well as mitochondrial component genes UCP3, COX, and NADH expression by 3&#8211;5 fold in C2C12 cells (p &lt; 0.003). Adipocyte-conditioned medium reduced mitochondrial abundance (p &lt; 0.001) and decreased UCP3 but increased PGC-1&#945; expression in myocytes, suggesting a feedback stimulation of mitochondrial biogenesis. Similar data were observed in C2C12 myocytes co-cultured with adipocytes, with co-culture markedly suppressing mitochondrial abundance (p &lt; 0.02). Leucine stimulated oxygen consumption in both C2C12 cells and adipocytes compared with either control or valine-treated cells. Transfection of C2C12 myocytes with SIRT-1 siRNA resulted in parallel suppression of SIRT-1 expression and leucine-induced stimulation of PGC-1&#945; and NRF-1, indicating that SIRT-1 mediates leucine induced mitochondrial biogenesis in muscle cells.
Conclusion:
These data suggest that leucine and calcitriol modulation of muscle and adipocyte energy metabolism is mediated, in part, by mitochondrial biogenesis.</description>
        <link>http://www.nutritionandmetabolism.com/content/6/1/26</link>
                <dc:creator>Xiaocun Sun</dc:creator>
                <dc:creator>Michael Zemel</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2009, 6:26</dc:source>
        <dc:date>2009-06-05T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-6-26</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>26</prism:startingPage>
        <prism:publicationDate>2009-06-05T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/6/1/25">
        <title>Effect of oral acetyl L-carnitine arginate on resting and postprandial blood biomarkers in pre-diabetics</title>
        <description>Background:
Resting and postprandial oxidative stress is elevated in those with metabolic disorders such as diabetes. Antioxidant supplementation may attenuate the rise in oxidative stress following feeding. Therefore we sought to determine the effects of acetyl L-carnitine arginate (ALCA) on resting and postprandial biomarkers of glucose and lipid metabolism, as well as oxidative stress.
Methods:
Twenty-nine pre-diabetic men and women were randomly assigned to either 3 g&#183;day-1 of ALCA (n = 14; 31 &#177; 3 yrs) or placebo (n = 15; 35 &#177; 3 yrs) in a double-blind design, to consume for eight weeks. Fasting blood samples were taken from subjects both pre and post intervention. After each fasting sample was obtained, subjects consumed a high fat, high carbohydrate meal and additional blood samples were taken at 1, 2, 4, and 6 hours post meal. Samples were analyzed for a variety of metabolic variables (e.g., glucose, HbA1c, lipid panel, C-reactive protein, nitrate/nitrite, and several markers of oxidative stress). Area under the curve (AUC) was calculated for each variable measured post meal, both pre and post intervention.
Results:
ALCA, but not placebo, resulted in an increase in nitrate/nitrite (25.4 &#177; 1.9 to 30.1 &#177; 2.8 &#956;mol&#183;L-1) from pre to post intervention, with post intervention values greater compared to placebo (p = 0.01). No other changes of statistical significance were noted (p &gt; 0.05), although ALCA resulted in slight improvements in glucose (109 &#177; 5 to 103 &#177; 5 mg&#183;dL-1), HbA1c (6.6 &#177; 1.1 to 6.2 &#177; 1.2%), and HOMA-IR (3.3 &#177; 1.3 to 2.9 &#177; 1.2). AUC postprandial data were not statistically different between ALCA and placebo for any variable (p &gt; 0.05). However, nitrate/nitrite demonstrated a moderate effect size (r = 0.35) for increase from pre (139.50 &#177; 18.35 &#956;mol&#183;L-1&#183;6 hr-1) to post (172.40 &#177; 21.75 &#956;mol&#183;L-1&#183;6 hr-1) intervention with ALCA, and the magnitude of decrease following feeding was not as pronounced as with placebo.
Conclusion:
Supplementation with ALCA results in an increase in resting nitrate/nitrite in pre-diabetics, without any statistically significant change in other metabolic or oxidative stress variables measured at rest or post meal.</description>
        <link>http://www.nutritionandmetabolism.com/content/6/1/25</link>
                <dc:creator>Richard Bloomer</dc:creator>
                <dc:creator>Kelsey Fisher-Wellman</dc:creator>
                <dc:creator>Patrick Tucker</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2009, 6:25</dc:source>
        <dc:date>2009-06-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-6-25</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>25</prism:startingPage>
        <prism:publicationDate>2009-06-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/6/1/24">
        <title>Dietary n-3-polyunsaturated fatty acids and energy balance in overweight or moderately obese men and women: a randomized controlled trial</title>
        <description>Background:
Dietary n-3-polyunsaturated fatty acids (n-3-PUFA) have been shown to reduce body weight and fat mass in rodents as well as in humans in one small short-term study. We conducted this controlled randomized dietary trial to test the hypothesis that n-3-PUFA lower body weight and fat mass by reducing appetite and ad libitum food intake and/or by increasing energy expenditure.
Methods:
Twenty-six overweight or moderately obese (body mass index 28&#8211;33 kg/m2) men and women were included, and received either a diet rich in n-3-PUFA from both plant and marine sources or a control diet. Diets were administered in an isocaloric fashion for 2 weeks followed by 12 weeks of ad libitum intake. The n-3-PUFA and control diets were identical in all regards except for the fatty acid composition. All foods were provided to subjects, and leftovers were weighed back to assess actual food intake accurately for each day of the study. This design gave us 80% power to detect a difference in weight change between the n-3-PUFA and control diet groups of 2.25 kg at an &#945;-error level of 5%.
Results:
Both groups lost similar amounts of weight when these diets were consumed ad libitum for 12 weeks [mean (SD): -3.5 (3.7) kg in the control group vs. -2.8 (3.7) kg in the n-3-PUFA group, F(1,24) = 13.425, p = 0.001 for time effect; F(1,24) = 0.385, p = 0.541 for time &#215; group interaction]. Consistent with this finding, we also found no differences between the n-3-PUFA and control groups with regard to appetite as measured by visual analogue scale, ad libitum food intake, resting energy expenditure as measured by indirect calorimetry, diurnal plasma leptin concentrations, or fasting ghrelin concentrations.
Conclusion:
Our results suggest that dietary n-3-PUFA do not play an important role in the regulation of food intake, energy expenditure, or body weight in humans.</description>
        <link>http://www.nutritionandmetabolism.com/content/6/1/24</link>
                <dc:creator>Mario Kratz</dc:creator>
                <dc:creator>Holly Callahan</dc:creator>
                <dc:creator>Pamela Yang</dc:creator>
                <dc:creator>Colleen Matthys</dc:creator>
                <dc:creator>David Weigle</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2009, 6:24</dc:source>
        <dc:date>2009-05-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-6-24</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>24</prism:startingPage>
        <prism:publicationDate>2009-05-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/6/1/23">
        <title>Effects of a popular exercise and weight loss program on weight loss, body composition, energy expenditure and health in obese women</title>
        <description>ObjectiveTo determine the safety and efficacy of altering the ratio of carbohydrate and protein in low-energy diets in conjunction with a popular exercise program in obese women.DesignMatched, prospective clinical intervention study to assess efficacy of varying ratios of carbohydrate and protein intake in conjunction with a regular exercise program.ParticipantsOne-hundred sixty one sedentary, obese, pre-menopausal women (38.5 &#177; 8.5 yrs, 164.2 &#177; 6.7 cm, 94.2 &#177; 18.8 kg, 34.9 &#177; 6.4 kg&#183;m-2, 43.8 &#177; 4.2%) participated in this study. Participants were weight stable and not participating in additional weight loss programs.
Methods:
Participants were assigned to either a no exercise + no diet control (CON), a no diet + exercise group (ND), or one of four diet + exercise groups (presented as kcals; % carbohydrate: protein: fat): 1) a high energy, high carbohydrate, low protein diet (HED) [2,600; 55:15:30%], 2) a very low carbohydrate, high protein diet (VLCHP) [1,200 kcals; 63:7:30%], 3) a low carbohydrate, moderate protein diet (LCMP) [1,200 kcals; 50:20:30%] and 4) a high carbohydrate, low protein diet (HCLP) [1,200 kcals; 55:15:30%]. Participants in exercise groups (all but CON) performed a pneumatic resistance-based, circuit training program under supervision three times per week.MeasurementsAnthropometric, body composition, resting energy expenditure (REE), fasting blood samples and muscular fitness assessments were examined at baseline and weeks 2, 10 and 14.
Results:
All groups except CON experienced significant reductions (P &lt; 0.05 &#8211; 0.001) in waist circumference over 14 weeks. VLCHP, LCHP and LPHC participants experienced similar but significant (P &lt; 0.05 &#8211; 0.001) reductions in body mass when compared to other groups. Delta responses indicated that fat loss after 14 weeks was significantly greatest in VLCHP (95% CI: -5.2, -3.2 kg), LCMP (-4.0, -1.9 kg) and HCLP (-3.8, -2.1 kg) when compared to other groups. Subsequent reductions in % body fat were significantly greater in VLCHP, LCMP and HCLP participants. Initial dieting decreased (P &lt; 0.05) relative REE similarly in all groups. All exercise groups significantly (P &lt; 0.05) improved in muscular fitness, but these improvements were not different among groups. Favorable but non-significant mean changes occurred in lipid panels, glucose and HOMA-IR. Leptin levels decreased (P &lt; 0.05) in all groups, except for CON, after two weeks of dieting and remained lower throughout the 14 week program. Exercise participation resulted in significant improvements in quality of life and body image.
Conclusion:
Exercise alone (ND) appears to have minimal impact on measured outcomes with positive outcomes apparent when exercise is combined with a hypoenergetic diet. Greater improvements in waist circumference and body composition occurred when carbohydrate is replaced in the diet with protein. Weight loss in all diet groups (VLCHP, LCMP and HCLP) was primarily fat and stimulated improvements in markers of cardiovascular disease risk, body composition, energy expenditure and psychosocial parameters.</description>
        <link>http://www.nutritionandmetabolism.com/content/6/1/23</link>
                <dc:creator>Chad Kerksick</dc:creator>
                <dc:creator>Ashli Thomas</dc:creator>
                <dc:creator>Bill Campbell</dc:creator>
                <dc:creator>Lem Taylor</dc:creator>
                <dc:creator>Colin Wilborn</dc:creator>
                <dc:creator>Brandon Marcello</dc:creator>
                <dc:creator>Mike Roberts</dc:creator>
                <dc:creator>Emily Pfau</dc:creator>
                <dc:creator>Megan Grimstvedt</dc:creator>
                <dc:creator>Jasmine Opusunju</dc:creator>
                <dc:creator>Teresa Magrans-Courtney</dc:creator>
                <dc:creator>Chris Rasmussen</dc:creator>
                <dc:creator>Ron Wilson</dc:creator>
                <dc:creator>Richard Kreider</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2009, 6:23</dc:source>
        <dc:date>2009-05-14T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-6-23</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>23</prism:startingPage>
        <prism:publicationDate>2009-05-14T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/6/1/22">
        <title>Detection of IgE, IgG, IgA and IgM antibodies against
raw and processed food antigens
</title>
        <description>Background:
Despite the first documented case of food allergy to cooked food in 1921 by Prausnitz and Kustner, all commercial food antigens are prepared from raw food. Furthermore, all IgE and IgG antibodies against dietary proteins offered by many clinical laboratories are measured against raw food antigens.
Methods:
We developed an enzyme-linked immunosorbent assay for the measurement of IgE, IgG, IgA and IgM antibodies against raw and processed food antigens. Sera with low or high reactivity to modified food antigens were subjected to myelin basic protein, oxidized low density lipoprotein, and advanced glycation end products (AGE) such as AGE-human serum albumin and AGE-hemoglobin.
Results:
Compared to raw food antigens, IgE antibodies showed a 3&#8211;8-fold increase against processed food antigens in 31% of the patients. Similarly, IgG, IgA and IgM antibodies against modified food antigens overall were found at much higher levels than antibody reactions against raw food antigens. Almost every tested serum with high levels of antibodies against modified food antigens showed very high levels of antibodies against myelin basic protein, oxidized low density lipoprotein, AGE-human serum albumin and AGE-hemoglobin.
Conclusion:
We conclude that the determination of food allergy, intolerance and sensitivity would be improved by testing IgE, IgG, IgA and IgM antibodies against both raw and processed food antigens. Antibodies against modified food antigens, by reacting with AGEs and tissue proteins, may cause perturbation in degenerative and autoimmune diseases such as diabetes, atherosclerosis, inflammation, autoimmunity, neurodegeneration and neuroautoimmunity.</description>
        <link>http://www.nutritionandmetabolism.com/content/6/1/22</link>
                <dc:creator>Aristo Vojdani</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2009, 6:22</dc:source>
        <dc:date>2009-05-12T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-6-22</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>22</prism:startingPage>
        <prism:publicationDate>2009-05-12T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/6/1/21">
        <title>Effects of a low-carbohydrate diet on glycemic control in outpatients with severe type 2 diabetes</title>
        <description>We previously demonstrated that a loosely restricted 45%-carbohydrate diet led to greater reduction in hemoglobin A1c (HbA1c) compared to high-carbohydrate diets in outpatients with mild type 2 diabetes (mean HbA1c level: 7.4%) over 2 years. To determine whether good glycemic control can be achieved with a 30%-carbohydrate diet in severe type 2 diabetes, 33 outpatients (15 males, 18 females, mean age: 59 yrs) with HbA1c levels of 9.0% or above were instructed to follow a low-carbohydrate diet (1852 kcal; %CHO:fat:protein = 30:44:20) for 6 months in an outpatient clinic and were followed to assess their HbA1c levels, body mass index and doses of antidiabetic drugs. HbA1c levels decreased sharply from a baseline of 10.9 &#177; 1.6% to 7.8 &#177; 1.5% at 3 months and to 7.4 &#177; 1.4% at 6 months. Body mass index decreased slightly from baseline (23.8 &#177; 3.3) to 6 months (23.5 &#177; 3.4). Only two patients dropped out. No adverse effects were observed except for mild constipation. The number of patients on sulfonylureas decreased from 7 at baseline to 2 at 6 months. No patient required inpatient care or insulin therapy. In summary, the 30%-carbohydrate diet over 6 months led to a remarkable reduction in HbA1c levels, even among outpatients with severe type 2 diabetes, without any insulin therapy, hospital care or increase in sulfonylureas. The effectiveness of the diet may be comparable to that of insulin therapy.</description>
        <link>http://www.nutritionandmetabolism.com/content/6/1/21</link>
                <dc:creator>Hajime Haimoto</dc:creator>
                <dc:creator>Tae Sasakabe</dc:creator>
                <dc:creator>Kenji Wakai</dc:creator>
                <dc:creator>Hiroyuki Umegaki</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2009, 6:21</dc:source>
        <dc:date>2009-05-06T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-6-21</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>21</prism:startingPage>
        <prism:publicationDate>2009-05-06T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/6/1/20">
        <title>White Tea extract induces lipolytic activity and inhibits adipogenesis in human subcutaneous (pre)-adipocytes</title>
        <description>Background:
The dramatic increase in obesity-related diseases emphasizes the need to elucidate the cellular and molecular mechanisms underlying fat metabolism. To investigate how natural substances influence lipolysis and adipogenesis, we determined the effects of White Tea extract on cultured human subcutaneous preadipocytes and adipocytes.
Methods:
For our in vitro studies we used a White Tea extract solution that contained polyphenols and methylxanthines. Utilizing cultured human preadipocytes we investigated White Tea extract solution-induced inhibition of triglyceride incorporation during adipogenesis and possible effects on cell viability. In vitro studies on human adipocytes were performed aiming to elucidate the efficacy of White Tea extract solution to stimulate lipolytic activity. To characterize White Tea extract solution-mediated effects on a molecular level, we analyzed gene expression of essential adipogenesis-related transcription factors by qRT-PCR and determined the expression of the transcription factor ADD1/SREBP-1c on the protein level utilizing immunofluorescence analysis.
Results:
Our data show that incubation of preadipocytes with White Tea extract solution significantly decreased triglyceride incorporation during adipogenesis in a dose-dependent manner (n = 10) without affecting cell viability (n = 10). These effects were, at least in part, mediated by EGCG (n = 10, 50 &#956;M). In addition, White Tea extract solution also stimulated lipolytic activity in adipocytes (n = 7). Differentiating preadipocytes cultivated in the presence of 0.5% White Tea extract solution showed a decrease in PPAR&#947;, ADD1/SREBP-1c, C/EBP&#945; and C/EBP&#948; mRNA levels. Moreover, the expression of the transcription factor ADD1/SREBP-1c was not only decreased on the mRNA but also on the protein level.
Conclusion:
White Tea extract is a natural source that effectively inhibits adipogenesis and stimulates lipolysis-activity. Therefore, it can be utilized to modulate different levels of the adipocyte life cycle.</description>
        <link>http://www.nutritionandmetabolism.com/content/6/1/20</link>
                <dc:creator>Jorn Sohle</dc:creator>
                <dc:creator>Anja Knott</dc:creator>
                <dc:creator>Ursula Holtzmann</dc:creator>
                <dc:creator>Ralf Siegner</dc:creator>
                <dc:creator>Elke Gronniger</dc:creator>
                <dc:creator>Andreas Schepky</dc:creator>
                <dc:creator>Stefan Gallinat</dc:creator>
                <dc:creator>Horst Wenck</dc:creator>
                <dc:creator>Franz Stab</dc:creator>
                <dc:creator>Marc Winnefeld</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2009, 6:20</dc:source>
        <dc:date>2009-05-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-6-20</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>20</prism:startingPage>
        <prism:publicationDate>2009-05-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.nutritionandmetabolism.com/content/6/1/19">
        <title>Effect of conjugated linoleic acids from beef or industrial hydrogenation on growth and adipose tissue characteristics of rats</title>
        <description>Background:
The conjugated linoleic acid (CLA) content of beef can be increased by supplementing appropriate beef cattle diets with vegetable oil or oil seed. Yet the effect of consumption of such beef on adipose tissue characteristics is unclear, thus the study was conducted to compare adipose tissue responses of rats to diets containing beef from steers either not provided or provided the oil supplements to alter CLA composition of the fat in muscle.
Methods:
Effects of feeding synthetic (industrial hydrogenation) CLA or CLA from beef on growth and adipose tissue responses of weanling, male, Wistar rats (n = 56; 14 per treatment diet) were investigated in a completely randomized design experiment. Diets were: control (CON) diet containing casein and soybean oil, synthetic CLA (SCLA) diet; where 1.69% synthetic CLA replaced soybean oil, two beef-diets; CONM and CLAM, containing freeze dried beef from steers either not fed or fed 14% sunflower seeds to increase CLA content of beef. Diets were isonitrogenous (20% protein) and isocaloric. Rat weights and ad libitum intakes were recorded every 2 wk. After 9 wk, rats were fasted for 24 h, blood sampled by heart puncture, sacrificed, tissue and organs were harvested and weights recorded. The adipose tissue responses with regard to cellularity and fatty acid compositions of retroperitoneal and inguinal adipose tissue were determined.
Results:
Body weights and gains were comparable, but organ weights as percent of body weight were greater for rats fed SCLA than CONM. Fasting blood glucose concentration was lower (p &lt; 0.01) in rats fed SCLA than those fed CONM or CLAM. Retroperitoneal and inguinal fat weights, as percent of body weight were greater (p &lt; 0.01) in rats fed CONM or CLAM than those fed CON or SCLA diets. Adipocyte numbers were least in retroperitoneal tissue of rats fed SCLA, while inguinal tissue cell density and total number were lower (p = 0.02) in rats fed CLAM (7.26 &#215; 107 cells/g and 8.03 &#215; 108 cells) than those fed CONM (28.88 &#215; 107 cells/g and 32.05 &#215; 108 cells, respectively).
Conclusion:
Study suggests that dietary CLA either as synthetic or high CLA-beef may alter adipose tissue characteristics by decreasing the number of adipocytes and by decreasing the size of the tissue.</description>
        <link>http://www.nutritionandmetabolism.com/content/6/1/19</link>
                <dc:creator>Mao He</dc:creator>
                <dc:creator>Priya Mir</dc:creator>
                <dc:creator>Erasmus Okine</dc:creator>
                <dc:creator>Helen Napadajlo</dc:creator>
                <dc:source>Nutrition &amp; Metabolism 2009, 6:19</dc:source>
        <dc:date>2009-04-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1743-7075-6-19</dc:identifier>
        <prism:publicationName>Nutrition &amp; Metabolism</prism:publicationName>
        <prism:issn>1743-7075</prism:issn>
        <prism:volume>6</prism:volume>
        <prism:startingPage>19</prism:startingPage>
        <prism:publicationDate>2009-04-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
